{"data":{"id":"us/21-cfr-522.158","jurisdiction":"us","citation":"21 CFR 522.158","heading":"Bedinvetmab.","body":"(a) Specifications. Each single-use vial contains 5, 10, 15, 20, or 30 milligrams (mg) bedinvetmab in an extractable volume of 1 milliliter.\n(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.\n(c) Conditions of use—(1) Amount. Administer 0.23 mg/pound (0.5 mg/kilogram) body weight monthly by subcutaneous injection.\n(2) Indications for use. For the control of pain associated with osteoarthritis in dogs.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"943d56db839b6a0d282023b6071b464bd6f772f23929c4ec91f0da94c5ea5393","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-522.150","next":"us/21-cfr-522.161"},"notice":"GroundRules: Original legal text. Not legal advice."}